The DEA Has Withdrawn It’s Notice of Intent to Ban Kratom For Now.

On August 31, 2016, DEA published in the Federal Register, a notice of its intent to place mitragynine and 7-hydroxymitragynine, two substances of the plant Mitragyna speciosa also referred to as kratom, in Schedule I.  Since publishing that notice, the DEA has received a number of comments from members of the public.  Some of the commenters offered their opinions regarding the pharmacological effects of mitragynine and 7-hydroxymitragynine.  To allow consideration of these comments, as well as others, the DEA has withdrawn its notice of intent to temporarily place Schedule I controls on Kratom and is soliciting public comments until December 1, 2016.

The DEA has also asked the Food and Drug Administration (FDA) to expedite its scientific and medical evaluation and scheduling recommendation for these substances, which the DEA previously requested.

With respect to mitragynine and 7-hydroxymitragynine, the DEA will consider all public comments received under the above procedures, as well as the FDA’s scientific and medical evaluation and scheduling recommendation for these substances.  Once the DEA has received and considered all of this information, the DEA will decide whether to proceed with scheduling of mitragynine and 7-hydroxymitragynine pursuant to the requirements of the Controlled Substances Act.

The DEA’s withdrawal notice and solicitation of comments may be found here:

It looks like it will be published today or tomorrow.
Thank you everyone for there hard work.  We will need to keep on this hard if we plan to win this next stage of keeping Kratom legal.